Subclinical leaflet thrombosis and anticoagulation strategy following trans-catheter aortic valve replacement: A systematic review.

Singam ShashankLalitha Devi BalireddiPugazhendi InbanSaud Muthanna Shakir Al-EzziNalla Jaipal ReddyYarub AlalousiPriyadarshi PrajjwalJobby JohnMohammed Abulgaith Ali ShajeriMohammed Khaleel I K H AlmadhounMukhamed SulaimanovBita AmiriMohammed Dheyaa Marsool Marsool Omniat Amir Hussin

Published in: Health science reports (2024)

The use of dual antiplatelet drugs in routine antithrombotic therapy tends to accelerate initial subclinical leaflet thrombosis after TAVI, which results in a developing restriction of leaflet mobility and an increase in pressure differences.

Keyphrases

aortic valve
aortic valve replacement
transcatheter aortic valve implantation
aortic stenosis
transcatheter aortic valve replacement
pulmonary embolism
atrial fibrillation
mitral valve
venous thromboembolism
clinical practice
left ventricular
stem cells
ejection fraction